Area: Gastroenterology
Location: Washington DC, United States
Date: October 20 to October 24
Description:
American Association for the study of Liver Diseases.
Risk of Hepatitis C transmission from antibody positive-nucleic acid negative liver organs to antibody negative recipients
Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality and Hepatocellular Carcinoma
Acute liver injury due to immunotherapy for metastatic cancer: a new challenge
Improved Short-Term Survival in HCV Patients following Liver Transplantation in the Era of Direct Acting Antiviral Agents
Integrated Efficacy and Safety of Glecaprevir/Pibrentasvir to Treat HCV Genotype 1-6 Infection in Patients Without Cirrhosis Including HIV Co-Infection
Gut Microbiota and Liver
HCV Patient Populations With Challenging Treatment Decisions
Multidisciplinary Approach to the Management of Hepatocellular Carcinoma
GI endoscopy in Patients with Liver disease